Qiagen N.V. (Nasdaq: QGEN) announced plans to significantly expand its existing portfolio of molecular assays used in next-generation sequencing (NGS) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE